Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer-Reference-Cited by-同舟云学术

Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer

Published:2021-12 Issue:5 Volume:3 Page:725-733
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Shanmuganathan Jan Walter Dhillon,Kragholm Kristian,Tayal Bhupendar,Polcwiartek Christoffer,Poulsen Laurids Østergaard,El-Galaly Tarec Christoffer,Fosbøl Emil Loldrup,D’Souza Maria,Gislason Gunnar,Køber Lars,Schou Morten,Nielsen Dorte,Søgaard Peter,Torp-Pedersen Christian Tobias,Mamas Mamas A.,Freeman Phillip

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference29 articles.

1. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development;Grem;Invest New Drugs,2000

2. The pharmacology of the fluoropyrimidines;Myers;Pharmacol Rev,1981

3. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study;de Forni;J Clin Oncol,1992

4. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk;Lestuzzi;Ann Oncol,2014

5. Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina;Stewart;Intern Med J,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy;International Journal of Radiation Oncology*Biology*Physics;2024-01

2. Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer;The American Journal of Cardiology;2023-11

3. Tailored to a Woman’s Heart: Gender Cardio-Oncology Across the Lifespan;Current Cardiology Reports;2023-10-11

4. Prevalence and outcomes of type 2 myocardial infarction in patients with cancer: A retrospective analysis from the National Inpatient Sample dataset;International Journal of Cardiology;2023-10

5. Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer;ESMO Open;2023-04